Adverum Biotechnologies (ADVM)
(Delayed Data from NSDQ)
$7.05 USD
+0.02 (0.28%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $7.03 -0.02 (-0.28%) 4:26 PM ET
2-Buy of 5 2
F Value C Growth D Momentum D VGM
Adverum Biotechnologies (ADVM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$30.00 | $40.00 | $12.00 | 326.74% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Adverum Biotechnologies comes to $30.00. The forecasts range from a low of $12.00 to a high of $40.00. The average price target represents an increase of 326.74% from the last closing price of $7.03.
Analyst Price Targets (7 )
Broker Rating
Adverum Biotechnologies currently has an average brokerage recommendation (ABR) of 1.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.25 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, seven are Strong Buy, representing 87.5% of all recommendations. A month ago, Strong Buy represented 87.5%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ADVM.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.25 | 1.25 | 1.25 | 1.25 | 1.29 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/19/2024 | Mizuho SecuritiesUSA | Graig Suvannavejh | Strong Buy | Strong Buy |
8/14/2024 | Cowen & Co. | Joseph Thome | Strong Buy | Strong Buy |
8/13/2024 | H.C. Wainwright & Co. | Matthew Caufield | Strong Buy | Strong Buy |
7/18/2024 | Chardan Capital Markets | Daniil Gataulin | Strong Buy | Strong Buy |
7/14/2024 | Truist Securities | Joon Lee | Strong Buy | Strong Buy |
7/9/2024 | Not Identified | Not Identified | Hold | Hold |
6/25/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
4/26/2024 | LadenburgThalmann | Aydin Huseynov | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.25 |
ABR (Last week) | 1.25 |
# of Recs in ABR | 8 |
Average Target Price | $30.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -1.20 |
ADVM FAQs
Adverum Biotechnologies, Inc. (ADVM) currently has an average brokerage recommendation (ABR) of 1.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Adverum Biotechnologies, Inc. (ADVM) is $30.00. The current on short-term price targets is based on 6 reports.
The forecasts for Adverum Biotechnologies, Inc. (ADVM) range from a low of $12 to a high of $40. The average price target represents a increase of $326.74 from the last closing price of $7.03.
The current UPSIDE for Adverum Biotechnologies, Inc. (ADVM) is 326.74%
Based on short-term price targets offered by seven analysts, the average price target for Adverum Biotechnologies comes to $30.00. The forecasts range from a low of $12.00 to a high of $40.00. The average price target represents an increase of 326.74% from the last closing price of $7.03.